221 related articles for article (PubMed ID: 17559826)
1. 1H NMR investigation on interaction between ibuprofen and lipoproteins.
Lan W; Zhu H; Zhou Z; Ye C; Liu M
Chem Phys Lipids; 2007 Aug; 148(2):105-11. PubMed ID: 17559826
[TBL] [Abstract][Full Text] [Related]
2. 1H NMR spectroscopic evidence of interaction between ibuprofen and lipoproteins in human blood plasma.
Yang Y; Bai G; Zhang X; Ye C; Liu M
Anal Biochem; 2004 Jan; 324(2):292-7. PubMed ID: 14690694
[TBL] [Abstract][Full Text] [Related]
3. 1H NMR at 800 MHz facilitates detailed phospholipid follow-up during atherogenic modifications in low density lipoproteins.
Soininen P; Oörni K; Maaheimo H; Laatikainen R; Kovanen PT; Kaski K; Ala-Korpela M
Biochem Biophys Res Commun; 2007 Aug; 360(1):290-4. PubMed ID: 17592725
[TBL] [Abstract][Full Text] [Related]
4. Remodeling of human plasma lipoproteins by detergent perturbation.
Pownall HJ
Biochemistry; 2005 Jul; 44(28):9714-22. PubMed ID: 16008356
[TBL] [Abstract][Full Text] [Related]
5. Partial filling affinity capillary electrophoresis with cationic poly(vinylpyrrolidone)-based copolymer coatings for studies on human lipoprotein-steroid interactions.
Wang AJ; Vainikka K; Witos J; D'Ulivo L; Cilpa G; Kovanen PT; Oörni K; Jauhiainen M; Riekkola ML
Anal Biochem; 2010 Apr; 399(1):93-101. PubMed ID: 19932676
[TBL] [Abstract][Full Text] [Related]
6. Lipid-protein interactions in human plasma LDL evidenced by magnetic resonance.
Kveder M; Marinić Z; Krisko A; Vikić-Topić D; Pifat G
Chem Phys Lipids; 2006 Jun; 141(1-2):225-9. PubMed ID: 16631150
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein inhibits in vitro oxidation of low-density lipoprotein.
Rufail ML; Ramage SC; van Antwerpen R
FEBS Lett; 2006 Oct; 580(22):5155-60. PubMed ID: 16962105
[TBL] [Abstract][Full Text] [Related]
8. The antioxidant properties of high-density lipoproteins in atherosclerosis.
Mackness B; Mackness M
Panminerva Med; 2012 Jun; 54(2):83-90. PubMed ID: 22525563
[TBL] [Abstract][Full Text] [Related]
9. [Changes in the surface charge of plasma lipoproteins during their auto-oxidation].
Panasenko OM; Azizova OA; Borin ML; Arnol'd K
Biull Eksp Biol Med; 1986 Jan; 101(1):24-6. PubMed ID: 3002515
[TBL] [Abstract][Full Text] [Related]
10. HDL enhances oxidation of LDL in vitro in both men and women.
Solakivi T; Jaakkola O; Salomäki A; Peltonen N; Metso S; Lehtimäki T; Jokela H; Nikkari ST
Lipids Health Dis; 2005 Oct; 4():25. PubMed ID: 16242018
[TBL] [Abstract][Full Text] [Related]
11. Effects of oxidation on the structure and stability of human low-density lipoprotein.
Jayaraman S; Gantz DL; Gursky O
Biochemistry; 2007 May; 46(19):5790-7. PubMed ID: 17444660
[TBL] [Abstract][Full Text] [Related]
12. [Determination of the surface charge of lipoproteins and its changes during lipid peroxidation].
Panasenko OM; Borin ML; Azizova OA; Arnol'd K
Biofizika; 1985; 30(5):822-7. PubMed ID: 2996626
[TBL] [Abstract][Full Text] [Related]
13. A dual role for lecithin:cholesterol acyltransferase (EC 2.3.1.43) in lipoprotein oxidation.
McPherson PA; Young IS; McEneny J
Free Radic Biol Med; 2007 Dec; 43(11):1484-93. PubMed ID: 17964419
[TBL] [Abstract][Full Text] [Related]
14. Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia.
Bai H; Liu BW; Deng ZY; Shen T; Fang DZ; Zhao YH; Liu Y
Free Radic Biol Med; 2006 May; 40(10):1796-803. PubMed ID: 16678017
[TBL] [Abstract][Full Text] [Related]
15. Oxidative interaction of unpaired hemoglobin chains with lipids and proteins: a key for modified serum lipoproteins in thalassemia.
Altamentova SM; Marva E; Shaklai N
Arch Biochem Biophys; 1997 Sep; 345(1):39-46. PubMed ID: 9281309
[TBL] [Abstract][Full Text] [Related]
16. Influence of dodecyl sulfate ions on the electrophoretic mobilities of lipoprotein particles measured by HPCE.
Cruzado ID; Hu AZ; Macfarlane RD
J Capillary Electrophor; 1996; 3(1):25-9. PubMed ID: 9384761
[TBL] [Abstract][Full Text] [Related]
17. Lipid fluidity at different regions in LDL and HDL of beta-thalassemia/Hb E patients.
Morales NP; Charlermchoung C; Luechapudiporn R; Yamanont P; Fucharoen S; Chantharaksri U
Biochem Biophys Res Commun; 2006 Nov; 350(3):698-703. PubMed ID: 17027920
[TBL] [Abstract][Full Text] [Related]
18. Evidence for distinct behaviour of phosphatidylcholine and sphingomyelin at the low density lipoprotein surface.
Murphy HC; Ala-Korpela M; White JJ; Raoof A; Bell JD; Barnard ML; Burns SP; Iles RA
Biochem Biophys Res Commun; 1997 May; 234(3):733-7. PubMed ID: 9175784
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel high-density lipoprotein antioxidant capacity assay and its application to high-density lipoprotein fractions.
Gaál K; Lőrincz H; Seres I; Harangi M; Oláh AV; Paragh G
Clin Biochem; 2013 Jun; 46(9):825-7. PubMed ID: 23353781
[TBL] [Abstract][Full Text] [Related]
20. Investigation of human low-density lipoprotein by (1)H nuclear magnetic resonance spectroscopy: mobility of phosphatidylcholine and sphingomyelin headgroups characterizes the surface layer.
Murphy HC; Burns SP; White JJ; Bell JD; Iles RA
Biochemistry; 2000 Aug; 39(32):9763-70. PubMed ID: 10933793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
